Advertisement

Topics

Advertisement

Solid Tumors

Hematologic Malignancies

Issues in Oncology

Supportive Care

Advertisement

Advertisement

Jun

18

Today In Oncology

Serum MicroRNAs for the Diagnosis of Pancreatic and Biliary Tract Cancers

TONIC: PD-1 Blockade in Metastatic Triple-Negative Breast Cancer

U.S. Cancer Survivors Numbered Nearly 17 Million at the Start of 2019

KEYNOTE-001: 5-Year Overall Survival With Pembrolizumab in Advanced NSCLC

Toxicity With Prostate-Only vs Prostate and Pelvic Lymph Node Intensity-Modulated Radiation Therapy

;

Advertisement

Most Read Stories

Resuming Immune Checkpoint Inhibitor Therapy After Immune-Mediated Diarrhea and Colitis

Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects

FDA Approves Pembrolizumab for the First-Line Treatment of Head and Neck Squamous Cell Carcinoma

2019 ASCO: CLL14 Trial Evaluates First-Line Venetoclax/Obinutuzumab in Previously Untreated CLL

MONALEESA-7 Shows Overall Survival Benefit for Ribociclib/Endocrine Therapy

Most Viewed Videos

Sara A. Hurvitz, MD, on HER2-Positive Breast Cancer: KRISTINE Trial on Neoadjuvant Trastuzumab, Pertuzumab, and Chemotherapy

Richard T. Penson, MD, and Don S. Dizon, MD, on Ovarian Cancer: SOLO3 Trial on Olaparib vs Chemotherapy in Relapsed Disease

Paul G. Richardson, MD, on Relapsed or Refractory Multiple Myeloma: Adding Isatuximab to Pomalidomide and Low-Dose Dexamethasone

Michael J. Morris, MD, on Metastatic Prostate Cancer: Adding Abiraterone Acetate to Enzalutamide

Hope S. Rugo, MD, and Matteo Lambertini, MD, PhD, on the SOPHIA Trial in HER2-Positive Metastatic Breast Cancer: Chemotherapy Plus Margetuximab vs Trastuzumab

© 2019 HSP News Service, L.L.C.